Tanaka E, Kinoshita H, Yoshida T, Kuroiwa Y
J Pharmacobiodyn. 1983 Jul;6(7):481-6. doi: 10.1248/bpb1978.6.481.
The purpose of this investigation is to correlate between trimethadione (TMO) metabolism and hepatic microsomal drug-oxidizing activities in different animal species (mouse, hamster, rat and rabbit). A good correlation was obtained between the plasma concentration ratio of 5,5-dimethyl-2,4-oxazolidinedione (DMO) to TMO and relative activities of aminopyrine (r = 0.999 at 1 h, p less than 0.01; r = 0.994 at 2 h, p less then 0.01) and TMO (r = 0.988 at 1 h, p less than 0.02; r = 0.975 at 2 h, p less than 0.05) N-demethylase, and aniline (r = 0.993 at 1 h, p less than 0.01; r = 0.979 at 2 h, p less than 0.01) hydroxylase. These results indicate that the values of plasma DMO/TMO ratio determined at an appropriate time period following its administration would be reflecting the degree of hepatic drug-oxidizing capacity in various experimental animal species. These findings thus suggest that in vivo TMO metabolism would be a useful drug for predicting hepatic drug-oxidizing capacity in humans.
本研究的目的是关联三甲双酮(TMO)代谢与不同动物物种(小鼠、仓鼠、大鼠和兔子)肝微粒体药物氧化活性之间的关系。5,5-二甲基-2,4-恶唑烷二酮(DMO)与TMO的血浆浓度比和氨基比林的相对活性之间获得了良好的相关性(1小时时r = 0.999,p < 0.01;2小时时r = 0.994,p < 0.01)以及TMO(1小时时r = 0.988,p < 0.02;2小时时r = 0.975,p < 0.05)N-脱甲基酶,和苯胺(1小时时r = 0.993,p < 0.01;2小时时r = 0.979,p < 0.01)羟化酶。这些结果表明,在给药后适当时间段测定的血浆DMO/TMO比值将反映各种实验动物物种肝药物氧化能力的程度。因此,这些发现表明体内TMO代谢将是预测人类肝药物氧化能力的一种有用药物。